Valiant Organics Limited · NSE:VALIANTORG
Valiant Organics — Q1 FY2024 Earnings Presentation
23 slides from Valiant Organics's earnings presentation, Aug 10, 2023
Slide 1: Exchange cover letter: Investor Presentation
August 10, 2023 To, To, Listing/Compliance Department Listing/Compliance Department BSE Limited National Stock Exchange of Phiroze Jeejeebhoy Towers, India Limited Dalal Street, “Exchange Plaza”, Plot No. C/1, Mumbai- 400 001. G Block Bandra-Kurla Complex, Bandra (E), Mumbai- 400 051. SCRIP CODE - 5
Slide 2: Earnings Presentation | Q1-FY24
Earnings Presentation | Q1-FY24
Slide 3: Snapshot
SNAPSHOT One of the largest chlorophenol One of the leading manufacturer of derivatives manufacturer globally Benzene derivatives products One of the largest domestic PNA One of the few commercial players in manufacturer Ortho Anisidine and Para Anisidine Diversified client base across Amongst 1st f
Slide 4: Company Overview
Company Overview Valiant Organics Limited was incorporated in 1984 by first generation technocrats and is headquartered out of Mumbai, India. The company is focused on the manufacturing and marketing of specialty chemicals which find usage in a variety of industries, including agrochemicals, pharmac
Slide 5: Chemistries And Product Basket
Chemistries And Product Basket Q1-FY24 Revenue Share Hydrogenation Chlorination 38% Key Products: Key Products: Industries Served: Industries Served: • Ortho Anisidine • Para ChloroPhenol (PCP) • Dyes • Agro Chemicals • Para Anisidine • Ortho ChloroPhenol (OCP) • Pigments • Cosmetics • IPPCA • 2,4 D
Slide 6: Manufacturing Footprint
Manufacturing Footprint CHLORINATION – SARIGAM HYDROGENATION & METHOXYLATION- • Capacity: 18,000 MTPA JHAGADIA UNIT 1 • Products: PCP, OCP, 2,4 DCP, 2,6 DCP, • Capacity: 27,000 MTPA 2,4,6 TCP • Products: ONA/OA, PNA/PA, IPPCA, CONVERSION PRODUCTS AMMONOLYSIS - VAPI HYDROGENATION – JHAGADIA UNIT 2 •
Slide 7: Key Strengths
Key Strengths Domain expertise and broad Plant locations are process understanding in a Wide supply chain strategically located near variety of chemistries. The provides the continuous ports to provide a executive team is made up of availability of adequate competitive advantage, first-generation te
Slide 8: Capex Projects
Capex Projects Product Project Status Remarks Commissioned • Currently, limited availability domestically and mostly imported Para Amino Phenol (PAP) Completed in Q4 FY’21 • Ramp up in the production ongoing to achieve the target by the end of FY’24 • Multi-purpose plant for forward integration with
Slide 9: Q1-FY24 Highlights
Q1-FY24 HIGHLIGHTS Valiant Organics Limited | Q1-2024 8
Slide 10: Q1-FY24 Consolidated Financial Highlights
Q1-FY24 CONSOLIDATED FINANCIAL HIGHLIGHTS INR 2,018 Mn Operational Revenue INR 239 Mn Operating EBITDA 11.84% Operating EBITDA Margin INR 149 Mn Profit After Tax 7.38% PAT Margin INR 4.44/ Share EPS Valiant Organics Limited | Q1-2024 9
Slide 11: Q1-FY24 Operational Highlights
Q1-FY24 Operational Highlights Q1-FY24 Revenue Break-up – Chemistries • Q1-FY24 was a subdued quarter owing to poor market conditions as a result of China opening up Others, 6% significantly, and continued inventory destocking and overall on-going geopolitical issues • While dyes & pigments continue
Slide 12: Key Chemistries: Revenues and Sales Volumes
Key Chemistries Chlorination (INR Mn) Hydrogenation (INR Mn) Ammonolysis (INR Mn) Others (INR Mn) 1, 200 1,036 1,045 752 800 180 159 579 612 138 700 1, 000 160 549 127 REVENUES 700 600 140 697 475 600 800 399 120 500 500 100 400 600 400 80 300 300 400 60 200 200 40 200 100 100 20 0 0 0 0 Q1-FY23 Q4-
Slide 13: Quarterly Consolidated Financial Performance
Quarterly Consolidated Financial Performance Particulars (INR Mn) Q1-FY24 Q1-FY23 Y-o-Y Q4-FY23 Q-o-Q Revenue from Operations 2,018 2,660 (24.1)% 2,714 (25.6)% Total Expenses 1,779 2,341 (24.0)% 2,191 (18.8)% EBITDA 239 319 (25.1)% 523 (54.3)% EBITDA Margins (%) 11.84% 11.99% (15) Bps 19.27% (743) B
Slide 14: Quarterly Standalone Financial Performance
Quarterly Standalone Financial Performance Particulars (INR Mn) Q1-FY24 Q1-FY23 Y-o-Y Q4-FY23 Q-o-Q Revenue from Operations 1,766 2,346 (24.7)% 2,272 (22.3)% Total Expenses 1,563 2,085 (25.0)% 1,831 (14.6)% EBITDA 203 261 (22.2)% 441 (53.9)% EBITDA Margins (%) 11.49% 11.13% 36 Bps 19.41% (792) Bps O
Slide 15: Historical Financial Overview
HISTORICAL FINANCIAL OVERVIEW Valiant Organics Limited | Q1-2024 14
Slide 16: Historical Consolidated Income Statement
Historical Consolidated Income Statement Particulars (INR Mn) FY21 FY22 FY23 Q1-FY24 Operational Income 7,548 11,533 10,518 2,018 Total Expenses 5,496 9,484 8,875 1,779 EBITDA 2,052 2,049 1,643 239 EBITDA Margins (%) 27.19% 17.77% 15.62% 11.84% Other Income 59 74 80 32 Depreciation 212 296 292 87 Fi
Slide 17: Consolidated Balance Sheet
Consolidated Balance Sheet Particulars (INR Mn) FY21 FY22 FY23 Particulars (INR Mn) FY21 FY22 FY23 EQUITY 5,086 6,489 7,401 Non-Current Assets 5,731 6,652 7,682 a) Equity Share Capital 272 272 272 a) Property, Plant and Equipment 4,967 5,303 6,565 b) Other Equity 4,747 5,856 6,616 c) Right-Of-Use As
Slide 18: Historical Standalone Income Statement
Historical Standalone Income Statement Particulars (INR Mn) FY21 FY22 FY23 Q1 FY24 Revenue from Operations 5,742 9,484 9,116 1,766 Total Expenses 4,170 7,811 7,817 1,563 EBITDA 1,572 1,673 1,299 203 EBITDA Margins (%) 27.38% 17.64% 14.25% 11.49% Other Income 169 33 29 2 Depreciation 186 273 276 82 F
Slide 19: Standalone Balance Sheet
Standalone Balance Sheet Particulars (INR Mn) FY21 FY22 FY23 Particulars (INR Mn) FY21 FY22 FY23 EQUITY 5,023 6,031 6,661 Non-Current Assets 5,798 6,787 7,424 a) Equity Share Capital 272 272 272 a) Property, Plant and Equipment 4,771 5,085 6,092 b) Other Equity 4,747 5,755 6,385 b) Right-Of-Use Asse
Slide 20: Consolidated Financial Highlights
Consolidated Financial Highlights Operational Revenue (INR Mn) EBITDA (INR Mn) & EBITDA Margins (%) PAT (INR Mn) & PAT Margins (%) 80.00% 1,309 1,279 2,052 2,049 14, 000 1, 400 11,533 2,100 70.00% 10,518 1,026 12, 000 1,800 1,643 1, 100 10, 000 60.00% 1,500 50.00% 8, 000 7,548 800 1,200 40.00% 27.19
Slide 21: Capital Market Information
Capital Market Information Share Price up to 30th June, 2023 70% 50% 30% 10% -10% -30% -50% -70% Jul-22 Aug-22 Sep-22 Oct-22 Nov-22 Dec-22 Jan-23 Feb-23 Mar-23 Apr-23 May-23 Jun-23 Valiant Organics Sensex Price Data (As on 30th June, 2023) INR Shareholding pattern (As on 30st June, 2023) Face Value
Slide 22: Disclaimer
Disclaimer Valiant Organics Limited No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all event
Slide 23: Thank You
THANK YOU Valiant Organics Limited | Q1-2024 22